
NRC Health
NRCNASDAQHealthcareMedical - Healthcare Information Services
Previous close
$22.19
+$0.37 · +1.70%
NRC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
67
Undervalued
Momentum
58
Neutral
Sentiment
69
Bullish
Risk resilience
59
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteNational Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Trent Green
- Listed since
- May 23, 2013
- Employees
- 357
Market position
Day range
Current $22.19
52-week range
Current $22.19
- Open
- $21.89
- Previous close
- $21.82
- Volume
- 339.03K
- 2.78× average
- Average volume
- 122.03K
- Average daily volume
- Market cap
- 500.09M USD
- Beta
- 0.37
- Market reference 1
- 50-day average
- $20.803
- +6.67% above average
- 200-day average
- $18.2357
- +21.68% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 495.02M USD
- P/E (TTM)
- 84.53×
- P/B (TTM)
- 74.57×
- P/S (TTM)
- 3.57×
- EV / EBITDA
- 16.38×
- Earnings yield
- 2.76%
- Free cash flow yield
- 3.75%
- Dividend yield
- 2.70%
Profitability & efficiency
- Gross margin
- 66.79%
- Operating margin
- 10.53%
- Net margin
- 4.18%
- Return on equity
- 82.92%
- Return on assets
- 8.60%
- Return on invested capital
- 14.36%
Financial health
- Debt / equity
- 13.75×
- Current ratio
- 0.55×
- Altman Z-score
- 3.34
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 137.39M USD | 143.06M USD | 148.58M USD | 151.57M USD | 147.95M USD |
| Cost of goods sold | 60M USD | 56.93M USD | 56.02M USD | 57.05M USD | 52.35M USD |
| Gross profit | 77.4M USD | 86.13M USD | 92.57M USD | 94.52M USD | 95.6M USD |
| Selling, general, and administrative | 54.81M USD | 44.91M USD | 46.58M USD | 42.7M USD | 38.96M USD |
| Operating expenses | 54.81M USD | 50.93M USD | 52.52M USD | 47.98M USD | 45.33M USD |
| Interest income | 111K USD | 125K USD | 820K USD | 168K USD | 14K USD |
| Interest expense | 4.76M USD | 2.6M USD | 862K USD | 1.21M USD | 1.67M USD |
| Depreciation and amortization | 7.62M USD | 6.02M USD | 5.9M USD | 5.28M USD | 6.37M USD |
| Operating income | 22.59M USD | 35.19M USD | 40.05M USD | 46.54M USD | 50.27M USD |
| Net income | 11.6M USD | 24.78M USD | 30.97M USD | 31.8M USD | 37.47M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 50%
- 1 beat, 1 miss, 0 met estimates
- Average EPS surprise
- +121.83%
- 2 comparable reports
- Latest EPS result
- 0.31
- Estimate -0.15 · Beat by 306.67%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
NRC news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$0.52
2025 complete year+8.3% since 2021
2026 partial: $0.32
$0.48
2,021
$0.84
2,022
$1.48
2,023
$0.48
2,024
$0.52
2,025
$0.32
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 25, 2026 | $0.16Quarterly | Sep 25, 2026 | Oct 9, 2026 |
Dividend | Jun 26, 2026 | $0.16Quarterly | Jun 26, 2026 | Jul 10, 2026 |
Dividend | Mar 27, 2026 | $0.16Quarterly | Mar 27, 2026 | Apr 10, 2026 |
Dividend | Dec 26, 2025 | $0.16Quarterly | Dec 26, 2025 | Jan 9, 2026 |
Dividend | Sep 26, 2025 | $0.12Quarterly | Sep 26, 2025 | Oct 10, 2025 |
Dividend | Jun 27, 2025 | $0.12Quarterly | Jun 27, 2025 | Jul 11, 2025 |
Ex-dividend Sep 25, 2026
$0.16
Quarterly
Record Sep 25, 2026 · Payment Oct 9, 2026
Ex-dividend Jun 26, 2026
$0.16
Quarterly
Record Jun 26, 2026 · Payment Jul 10, 2026
Ex-dividend Mar 27, 2026
$0.16
Quarterly
Record Mar 27, 2026 · Payment Apr 10, 2026
Ex-dividend Dec 26, 2025
$0.16
Quarterly
Record Dec 26, 2025 · Payment Jan 9, 2026
Ex-dividend Sep 26, 2025
$0.12
Quarterly
Record Sep 26, 2025 · Payment Oct 10, 2025
Ex-dividend Jun 27, 2025
$0.12
Quarterly
Record Jun 27, 2025 · Payment Jul 11, 2025
NRC peers
ETFs holding NRC
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI9.72M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM6.61M0.01%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF2.95M0.00%93.7B USD0.05%$245.53+0.82%
U.S. Micro Cap Portfolio ETFDFMC2.61M0.03%8.06B USD0.43%$60.95+0.73%
WisdomTree U.S. SmallCap Dividend FundDES2.44M0.12%2.24B USD0.38%$40.83+0.39%
iShares Russell 2000 Growth ETFIWO2.42M0.02%15.16B USD0.24%$387.37+1.24%
iShares U.S. Small-Cap Equity Factor ETFSMLF1.44M0.03%4.3B USD0.15%$89.29+0.80%
Schwab U.S. Small-Cap ETFSCHA1.41M0.01%23.1B USD0.03%$34.83+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 9.72M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 6.61M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 2.95M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
U.S. Micro Cap Portfolio ETFDFMC- Market value
- 2.61M
- Weight
- 0.03%
- AUM
- 8.06B USD
- Expense ratio
- 0.43%
- Price / 1D
- $60.95+0.73%
WisdomTree U.S. SmallCap Dividend FundDES- Market value
- 2.44M
- Weight
- 0.12%
- AUM
- 2.24B USD
- Expense ratio
- 0.38%
- Price / 1D
- $40.83+0.39%
iShares Russell 2000 Growth ETFIWO- Market value
- 2.42M
- Weight
- 0.02%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
iShares U.S. Small-Cap Equity Factor ETFSMLF- Market value
- 1.44M
- Weight
- 0.03%
- AUM
- 4.3B USD
- Expense ratio
- 0.15%
- Price / 1D
- $89.29+0.80%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 1.41M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
Continue in GoAI
Research NRCresearch.disclaimer











